CXCL8 and chronic obstructive pulmonary disease: -Resveratrol inhibited the release of inflammatory cytokines and chemokines (GM-CSF and CXCL8) by activated alveolar macrophages from COPD patients, table (4) (Culpitt et al., 2003).-Resveratrol used as an additional treatment for SARS-CoV-2 infection in order to minimise inflammation by reducing the cytokine storm (Marinella, 2020).Clinical.Trials.gov: NCT04400890, NCT04799743, NCT04542993